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Abstract
Purpose The purpose is to evaluate the interdevice and inter-
observer agreements between the SL SCAN-1 (a FD-OCT
integrated into a common slit lamp) and a standard stand-
alone FD-OCT device (the Cirrus) with regard to the presence
or absence of signs of leakage in the retina in patients with
exudative AMD and treated with anti-VEGF.
Methods Fifty-six patients, known to have exudative AMD
and under treatment with anti-VEGF agents, were included.
During a regular follow-up, OCT scans were made with the
Cirrus (macular-cube pattern) and the SL SCAN-1 (radial-
scan pattern). All scans were graded by two medical retina
specialists for signs of intraretinal cysts, subretinal fluid accu-
mulation, and thickening of the neurosensory retina. Presence
of signs of leakage was concluded if one or more of the three
signs were present.
Results In 91 % of the patients, the observers made identical
conclusions for both devices of the presence of signs of leak-
age, resulting in an interdevice Kappa coefficient of 0.87. For
the scans with disagreement about the presence or absence of
signs of leakage, positive and negative conclusions were
equally distributed between both devices, and differences
were restricted to more subtle signs of leakage.
Conclusion The interdevice Kappa coefficient of 0.87 shows
a high agreement between the SL SCAN-1 and the Cirrus in
grading signs of leakage in exudative AMD. OCT images play
a pivotal role in the diagnosis and management of exudative
diseases like AMD, and the SL SCAN-1 provides a very effi-
cient approach to these patients with the integration of the FD-
OCT device into a common slit lamp.
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Introduction
Optical Coherence Tomography (OCT) is a non-invasive,
non-contact imaging technique, providing images with de-
tailed information of different structures of the eye. OCT has
quickly evolved into a fast versatile imaging method, routine-
ly used in the ophthalmic clinic. Currently, several Fourier
Domain (FD)-OCT systems are commercially available. An
alternative to these stand-alone systems is an FD-OCT-device
integrated into a slit lamp. This SL SCAN-1 is an OCT device
integrated into a common slit lamp with the ability to make
OCT images of the anterior and posterior segments [1]. With
the flexibility of the slit lamp, one can make OCT-scans of the
observed area of interest during slit lamp biomicroscopy. The
OCT scans are shown directly on a computer screen for inter-
pretation. The OCT scans of the posterior segment can be
made through a handheld lens, while the alignment for the
sample arm is corrected by a fast Z-axis tracking system. With
the use of a handheld lens, the part of the retina of which OCT
sans can be made is identical to the field of view of the hand-
held lens. Basically, Bwhat one can see is what one can scan.^
With a handheld lens or a 3-mirror-contact lens even the far
peripheral retina can be scanned, which has an added
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diagnostic value, for example, in the differentiation between
senile retinoschisis and retinal detachment [2].
Next to the handheld lens, a specifically designed fixed
lens (the fundus viewer) can be used to make scans of the
posterior pole. By reducing the slit lamp beam to a small
central light spot, this spot can be used as a central fixation
point. Although this precludes the simultaneous view of the
posterior pole, the combination of the fundus viewer with the
central fixation spot ensures that one can easily make reliable
and repeatable scans around the fixation point of the eye.
Nowadays, the OCT has a crucial role in the evaluation of
patients with exudative retinopathies such as diabetic retinop-
athy and age-related macular degeneration (AMD). Often
based on the presence or absence of signs of active leakage
on OCT images, the decision is made to (re-)treat or to defer
treatment with anti-VEGF injections [3].
This study evaluated the interdevice and interobserver
agreement between the SL SCAN-1 and a standard stand-
alone FD-OCT device, the Cirrus HD-OCT 4000 (Zeiss), with
regard to the presence or absence of signs of leakage in the
retina in patients with exudative AMD and treated with anti-
VEGF.
Patients and methods
Fifty-eight patients with exudative AMD were invited for this
study. Two patients were excluded because of insufficient
quality of the OCT scans to be used for analysis due to cata-
ract. All 56 included patients were treated with anti-VEGF at
the eye-hospital Zonnestraal, Hilversum, the Netherlands, and
they were examined during a regular follow-up visit in the
course of their treatment, between March and May 2011. All
patients had received at least one previous series of intraocular
injections, and presented with more subtle signs of leakage,
instead of the more pronounced presence of signs of leakage at
the time of their first treatment.
The study followed the tenets of the Declaration of
Helsinki, and all patients gave their informed consent.
All patients received mydriatic eyedrops in the exam-
ined eye (tropicamide and phenylephrine) and OCT
scans were made by two experienced examiners, one
using the SL SCAN-1 (Topcon) and one using the Cir-
rus HD-OCT 4000 (Zeiss). Both examiners were
masked for the scans of the other examiner.
The SL SCAN-1 is a Fourier Domain Optical Coher-
ence Tomography (FD-OCT) system with a broadband
superluminescent diode (SLD) light source (bandwidth
Δλ=30 nm, central wavelength 840 nm), resulting in
a axial resolution of 8 μm to 9 μm in tissue. The scan
speed is 5000 A-scans per second and each B-scan is
composed of 512 A-scans. Although scans can be made
through a handheld lens, in this study scans were made
through the fundus viewer lens designed by Topcon, a
60D Volk lens fixed in a lens holder. The lens is slight-
ly tilted with respect to the optical path of the scanning
beam to avoid reflexes of the lens surface. The stand
has a detachable connection with the compatible slit
lamps (Topcon model SL-D2/D4/D7/D8Z, Haag-Streit
900 series) and is positioned in the central channel of
the common axis of the slit lamp. The working distance
of the lens is approximately 13 mm, and can be adjusted
with a knob on the side of the stand supporting a range of +5
to −15 diopter. With the fixed lens, one can use the light
beam of the slit lamp, reduced to a small spot, as a central
fixation light for the patient, parallel aligned to the OCT
scanning beam. By using the slit lamp light as a fixation
spot, the simultaneous view on the retina is precluded. In
the present study, six line scans (with a length of 6 mm)
were made with the SL SCAN-1 in a radial-scan pattern
oriented 30 ° from one another around the fixation point.
The Cirrus OCT scans were made using the Macular Cube
512x128 pattern, covering an area of 6x6 mm, with the
patient looking to the fixation point. The Cirrus has a
SLD light source with a central wavelength of 840 nm,
resulting in a axial resolution of 5 μm in tissue. The scan
speed is 27,000 A-scans per second and each B-scan is
composed of 512 A-scans.
All OCT scans of this study were of sufficient image qual-
ity. The Cirrus uses the Signal Strength (SS) with a discrete
scale of 1 to 10. Previous studies have shown a value of 6 or
more to deliver images of sufficient quality to be reliably used
Fig. 1 Both OCT scans (left
Cirrus, right SL SCAN-1), made
in the same eye of a patient, are of
sufficient quality for grading
(Cirrus SS>6, SL SCAN-1 QF>
60)
38 Graefes Arch Clin Exp Ophthalmol (2016) 254:37–41
in the clinic. The SLSCAN-1 uses a Quality Factor, from 0 to
100, and a value of 60 as the cutoff value for reliable clinical
use is recommended.
Two observers, medical retina specialists experienced in
the treatment of exudative AMD and reading of OCT images,
graded in a random order all OCT scans independently. Both
observers were masked for each other’s grades, for the course
of the patients' AMD, and their response to treatment.
The scans were graded for signs of active leakage, presence
or absence of intraretinal cysts (IRC), of subretinal fluid accu-
mulation (SRF), or thickening of the neurosensory retina
(Neuro Retinal Thickness, NRT). The NRT was estimated
by the observers and not based on topographic maps. If one
or more of these three signs was present, the OCT scan was
graded as presence of signs of leakage.
The Cohen’s Kappa coefficients, most accurate for a dichot-
omous variable, were calculated to assess the interdevice and
the interobserver agreements. After calculating the interdevice
Cohen’s kappa coefficient per observer, an overall kappa coef-
ficient was calculated by averaging. Similar analysis was per-
formed to obtain the interobserver agreement. Commercial soft-
ware (SPSS, version 16) was used for analysis.
Results
Fifty-six patients diagnosed with exudative AMD and treated
with anti-VEGF were included in this study. The mean age of
all subjects was 80 years (range of 55–96 years), and 37 of
them were female. OCT scans could be made in all 56 eyes
with both the SL SCAN-1 and the Cirrus; all scans were of
sufficient quality for grading (Cirrus SS>6, SL SCAN-1 QF>
60). An example of the OCT scans made with both devices in
one patient is shown in Fig. 1. In 13 eyes out of the 56 patients,
there was not any sign of leakage seen by both observers on
both devices. The interdevice agreements are shown in Table 1.
A Kappa coefficient of 0.87 was calculated for the presence or
absence of signs of leakage, and the table shows a good to
superior agreement between the devices for each individually
graded sign. Figure 2 shows the percentage of OCT scans
receiving identical grades per patient, with a unanimous
84 % for the presence or absence of signs of leakage. In
7.3 % (n=4) a discrepancy in grading was present between
observers, but each observer graded the OCT scan of both
devices equal. Overall, in 91 % of the patients the observer's
conclusion based on the SL SCAN-1 was identical to the
one based on the Cirrus. Figure 3 shows the absolute num-
ber of disagreements between the devices, favouring the
positive findings per device. This number consisted of pa-
tients where both observers graded differently with both de-
vices, and patients where only one of the observers differed
in his grading between the two devices. For example: for
only one patient both observers concluded that there were
signs of leakage on the OCT scan made with the Cirrus and
not on the scans made with the SL SCAN-1. In four pa-
tients, only one of the observers differed in his grading
between scans made with the two devices (in two patients
signs of leakage were seen only on the SL SCAN-1, and in
another two patients only on the Cirrus). Table 2 shows the
Kappa coefficient for the interobserver agreements. For the
Table 1 Interdevice agreement
Kappa coefficient 95 % CI




* Presence of signs of leakage based on the presence of one ormore of the
following signs: intraretinal cysts (IRC), subretinal fluid (SRF), or neuro-
sensory retina thickening (NRT)
Kappa coefficient is an average of the interdevice kappa coefficient of
each observer
Fig. 2 Percentage agreement between devices; percentage of OCT scans
receiving identical conclusions of the observers per sign and per patient.
For example: in 84 % both observers concluded identically for the
presence or absence of signs of leakage based on scans of both devices,
and in 7.3 %, both observers differed in their judgment of presence or
absence of signs of leakage, but each observer graded the OCT scan on
both devices to be equal
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outcome "signs of leakage" the kappa was 0.75, which can
be interpreted as a substantial agreement. Discrepancy be-
tween observers in the outcome "signs of leakage" was
found in nine patients. In four of these nine patients, the
observer made the same conclusion based on the scans of
both devices, but differed in his conclusion with the other
observer. The outcome "presence of signs of leakage" was
based on the presence of intraretinal cysts, and / or subretinal
fluid accumulation and / or thickening of the neurosensory
retina. Of these signs, the highest agreements (interobserver
and interdevice) were found for subretinal fluid and the low-
est for thickening of the neurosensory retina.
Discussion
This study shows that the OCT scans made with the SL
SCAN-1, an OCT-device integrated into a slit lamp, have a
comparable accuracy to detect signs of leakage in patients
with exudative AMD as the scans made with the Cirrus, a
representative commonly used stand-alone FD-OCT device.
In 91 % of the patients, an identical conclusion was made for
the presence or absence of signs of leakage based on the OCT
scans of both devices by each observer, with a kappa of 0.87.
This means that the scans of both devices are of a comparable
quality to grade signs of leakage.
The outcome "signs of leakage" is based on one or more
of the following signs: intraretinal cysts, subretinal fluid, and
neurosensory retina thickening. Of these signs, SRF had the
highest percentage of unanimous agreement between devices
(see Fig. 2), which resulted in an interdevice agreement
Kappa coefficient of 0.89 (Table 1). The interdevice agree-
ment of neurosensory retina thickening was the lowest with
a value of 0.76. An explanation for the variety in agreement
between these two signs could be that subretinal fluid is,
even when minimally present, a clear sign on an OCT scan.
Thickening of the retina can be subtle and is more influ-
enced by a subjective interpretation. In this study no actual
measurements of the retinal thickness were made, and thick-







Leakage IRC NRT SRF
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sl scan Cirrus sl scan Cirrus sl scan Cirrus
Fig. 3 Comparison between the devices of discordant OCT scans,
favouring positive findings, meaning the presence of a certain sign.
Absolute number of disagreements in observations between the devices,
favouring the positive findings per device. This includes all the OCT
scans of the patients graded differently on the two devices, not related
to the observer. For example: presence or absence of signs of leakage:
both observers concluded that in one patient signs of leakage were present
on the OCTscanmade with the Cirrus and not on the scans made with the
SL SCAN-1 (black). In four patients (grey), only one of the observers
differed in his grading between scans made with the two devices (in two
patients, signs of leakage was seen only on the SL SCAN-1, and in
another two patients only on the Cirrus)
Table 2 Interobserver agreement
Kappa coefficient 95 % CI




* Presence of signs of leakage based on the presence of one ormore of the
following signs: intraretinal cysts (IRC), subretinal fluid (SRF), or neuro-
sensory retina thickening (NRT)
Kappa coefficient is an average of the interobserver kappa coefficient of
each device
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retinal thickness measurements as provided by the segmen-
tation software of any OCT device is often unreliable in
patients with exudative AMD as a consequence of artefacts
due to the complex structural changes in the outer retina.
[4–6]. Consequently, clinicians need to estimate most of
the time pathological increases in retinal thickness. As could
be expected, the highest disagreement between the devices
and the lowest kappa was found for the subjective interpre-
tation of the sign neurosensory retinal thickening (Fig. 2,
Table 2). In case one of the devices, Cirrus or SL SCAN-
1, would have been more sensitive to detect subtle signs of
leakage, one would expect in cases of disagreement between
the devices, the most sensitive device to be more often pos-
itive for the presence of signs of leakage. In reality, as
shown in Fig. 3, the disagreement occurred without prefer-
ence for one or the other device.
There are important differences between the SL SCAN-1
and the Cirrus that should be taken into account. The Cirrus
images were made with a cube scan of 128 scan lines with an
axial resolution of 5μm. The SL SCAN-1 was operated with a
radial-scan pattern of six lines with an axial resolution of 8–
9 μm. Consequently, the scans of the SL SCAN-1 are denser
near the centre of the macula and much less dense at the edges
of the scan pattern compared to the cube scan of the Cirrus.
Signs of leakage not centrally located, therefore, could be
missed with this setup, although this was not reflected in the
results. The higher number of scan lines and the higher reso-
lution of the scans made with the Cirrus were not clearly
reflected in the results of this study.
Only Bsubstantial^ agreements were found for the in-
terobserver Kappa coefficients. This study was per-
formed in a clinical setting and experienced observers,
specialists in treating exudative AMD, graded the OCT
images. This study confirms that there is a rather large
variation in the interpretation of scans in clinical prac-
tice, between different observers, as mention in other
papers [7–9]. The observed variation is at the same
order of magnitude as in these previous studies.
With the SL SCAN-1 a fixation light is offered to the pa-
tient by using the light beam of the slit lamp reduced to a small
spot. This precludes the simultaneous view of the retina. Al-
though a few patients had an eccentric fixation, all patients
were asked to observe the central fixation light during imaging
with both devices. There was no difference between the two
devices in the position of the imaged area of the retina. How-
ever, using most standard OCT devices, it is possible to ob-
serve the macula before scanning and adjust the position of the
scanned area in case of overt eccentric fixation; this is not
possible with the SL SCAN-1 when the light beam is reduced
to a small fixation spot.
A shortcoming of the present study is that the observers
were not masked for the devices. The type of scan pattern
immediately identifies the used device, and therefore, masking
for the device was not possible.
In conclusion, the SL SCAN-1 enables viewing and scan-
ning the retina simultaneously, providing a very efficient ap-
proach to the patient with a retinal disease. The OCT scan is
central in the decision to (re)treat a patient with wAMD show-
ing the presence or absence of signs of leakage. This study
shows that, in almost all patients with wAMD, identical clin-
ical decisions with regard to signs of leakage are made based
on the OCT scans made with either the SL SCAN-1 or the
Cirrus OCT.
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